Vivos Therapeutics, Inc. (VVOS)

0.23 -12.79% (-0.03)

Over 1Y: -95.2%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 4.5M Q3 '21 — Operating Cash Flow: -4.1M Q3 '21 — Free Cash Flow: -4.5M Q3 '21 — Net Income: -5.5M Q4 '21 — Revenue: 4.4M Q4 '21 — Operating Cash Flow: -4.1M Q4 '21 — Free Cash Flow: -4.5M Q4 '21 — Net Income: -7.4M Q1 '22 — Revenue: 3.6M Q1 '22 — Operating Cash Flow: -6.1M Q1 '22 — Free Cash Flow: -6.2M Q1 '22 — Net Income: -5.3M Q2 '22 — Revenue: 4.2M Q2 '22 — Operating Cash Flow: -4.7M Q2 '22 — Free Cash Flow: -5.2M Q2 '22 — Net Income: -7M Q3 '22 — Revenue: 4.2M Q3 '22 — Operating Cash Flow: -5.8M Q3 '22 — Free Cash Flow: -5.9M Q3 '22 — Net Income: -5.4M Q4 '22 — Revenue: 4M Q4 '22 — Operating Cash Flow: -3M Q4 '22 — Free Cash Flow: -3.2M Q4 '22 — Net Income: -6.1M Q1 '23 — Revenue: 3.9M Q1 '23 — Operating Cash Flow: -3.5M Q1 '23 — Free Cash Flow: -3.8M Q1 '23 — Net Income: -1.7M Q2 '23 — Revenue: 3.4M Q2 '23 — Operating Cash Flow: -2.9M Q2 '23 — Free Cash Flow: -3.1M Q2 '23 — Net Income: -5.5M Q3 '23 — Revenue: 3.3M Q3 '23 — Operating Cash Flow: -2.8M Q3 '23 — Free Cash Flow: -3M Q3 '23 — Net Income: -2.1M Q4 '23 — Revenue: 3.2M Q4 '23 — Operating Cash Flow: -2.7M Q4 '23 — Free Cash Flow: -2.9M Q4 '23 — Net Income: -4.3M Q1 '24 — Revenue: 3.4M Q1 '24 — Operating Cash Flow: -2.5M Q1 '24 — Free Cash Flow: -2.7M Q1 '24 — Net Income: -3.8M Q2 '24 — Revenue: 4.1M Q2 '24 — Operating Cash Flow: -3M Q2 '24 — Free Cash Flow: -3.1M Q2 '24 — Net Income: -1.9M Q3 '24 — Revenue: 3.9M Q3 '24 — Operating Cash Flow: -4.2M Q3 '24 — Free Cash Flow: -4.4M Q3 '24 — Net Income: -2.6M Q4 '24 — Revenue: 3.7M Q4 '24 — Operating Cash Flow: -2.9M Q4 '24 — Free Cash Flow: -3.1M Q4 '24 — Net Income: -2.8M Q1 '25 — Revenue: 3M Q1 '25 — Operating Cash Flow: -3.8M Q1 '25 — Free Cash Flow: -3.9M Q1 '25 — Net Income: -3.9M Q2 '25 — Revenue: 3.8M Q2 '25 — Operating Cash Flow: -3.5M Q2 '25 — Free Cash Flow: -4.3M Q2 '25 — Net Income: -5M Q3 '25 — Revenue: 6.8M Q3 '25 — Operating Cash Flow: -4.2M Q3 '25 — Free Cash Flow: -4.2M Q3 '25 — Net Income: -5.4M Q4 '25 — Revenue: 3.8M Q4 '25 — Operating Cash Flow: -3.8M Q4 '25 — Free Cash Flow: -5.3M Q4 '25 — Net Income: -6.9M Q1 '26 — Revenue: 5.1M Q1 '26 — Operating Cash Flow: -6M Q1 '26 — Free Cash Flow: -6M Q1 '26 — Net Income: -7.7M Q2 '26 — Revenue: 5.2M Q2 '26 — Operating Cash Flow: -3.1M Q2 '26 — Free Cash Flow: -3.6M Q2 '26 — Net Income: -5.5M -6M -3M 0 3M 6M 9M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.4
OE margin -92.4%
Oper. margin -107.9%
ROIC -613.6%
Accruals -34.5%
Gross margin 61.9%
EBITDA margin -99.4%
FCF margin -91.0%
OCF margin -82.0%
Profit margin -121.8%
ROA -105.4%
ROCE -600.7%
OCF / EBIT —
ROE —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.6
RPO / sales 0.028×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.21×
Cash / Debt 0.21×
F-score 2.0 pts
Quick ratio 0.21×
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.1
Sales CAGR 4Y +0.82%
Sales/sh Y/Y -29.1%
Sales Q/Q +34.9%
Shares change +104.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.